Option chain shows key data for Medicine Man Technologies's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Medicine Man Technologies.

Medicine Man Technologies (OTC:SHWZ) Stock, Option Chain

Medicine Man Technologies

Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.

Debt In The US

Cannabis

Earnings

News

SHWZ

Schwazze&#39;s Q3 Preliminary Revenue Slides As Debt Grows, 2023 Financials Face Re-Audit

AI-Generated Image

Market Summary

Retail Sales

Markets

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

TCNNF

VRNOF

The Colorado Department of Revenue reported 673 cannabis dispensaries by the end of August, with an average revenue of $162,000 per store.

Is Colorado&#39;s Cannabis Market Back On Track? A 5% Sales Boost Says Yes

280E CANNABIS

Economics

CRLBF

GLASF

MRMD

Removing 280E in 2025 could drastically improve cash flow for cannabis companies. See how major MSOs like Green Thumb, Trulieve, and Cresco..

Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025

MEDICINE MAN TECH INC by Medicine Man Technologies Inc.

Medicine Man Technologies Inc

<a href="https://www.ft.com/content/c61e57aa-3f63-40fa-853a-cfc0eeffc7b0" title="https://www.ft.com/content/c61e57aa-3f63-40fa-853a-cfc0eeffc7b0">https://www.ft.com/content/c61e57aa-3f63-40fa-853a-cfc0eeffc7b0</a>

Management

Global

'Three Bank Of America Bankers In India Depart Over Alleged Client Tips' - Financial Times

Wall Street witnessed a positive momentum on Thursday as investor risk appetite remained resilient despite escalating geopolitical tensions in Europe. The market brushed off concerns following a Russian missile strike on a Ukrainian military facility overnight, which came in response to Ukrainian missile <a href="https://www.benzinga.com/24/11/42113449/natural-gas-prices-spike-to-over-1-year-highs-oil-surges-to-70-as-russia-fires-intercontinental-ballistic-missile-to-ukraine">attacks earlier this week. </a>
Russian President Vladimir Putin, in a televised address on Thursday, stated that after the use of long-range missiles from Ukraine, &#8220;the regional conflict gained elements of global one.&#8221;
Major U.S. indices traded higher by midday trading in New York, with standout performances among blue-chip stocks and small-cap equities. 
The Dow Jones Industrial Average surged 500 points, reaching 43,965, marking a 1.3% gain and its strongest session in over two weeks.
The Russell 2000 outperformed with a 1.7% jump, setting up its best day since the post-election rally. 
In contrast, the Nasdaq 100 lagged slightly, rising 0.5%. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), despite higher-than-expected earnings, failed to spark broader optimism in the tech sector. Meanwhile, shares of Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) tumbled nearly 6% after the Department of Justice (DOJ) mandated the sale of Google Chrome aimed at curbing Google&#8217;s dominant position in search and digital advertising.
Geopolitical uncertainties drove strong gains in the commodities market. <a href="https://www.benzinga.com/news/global/24/11/42118286/7-us-natural-gas-stocks-to-watch-as-henry-hub-prices-surge-50-in-november">Natural gas Henry Hub prices </a>soared 5%, bringing year-to-date gains to over 50% and marking the best monthly performance since July 2022. Crude oil prices also climbed 0.9%, supported by supply concerns.
Gold extended its winning streak, rising 0.7% for its fourth consecutive session of gains as investors sought safe-haven assets.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) continued its rally, rising over 3% and hitting an intraday high of $98,367. The largest cryptocurrency now hovers tantalizingly close to the $100,000 milestone. 
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,365.25</td>
<td>1.7%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,965.39</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,949.37</td>
<td>0.5%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,739.86</td>
<td>0.4%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent111924&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.6% to $593.78.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;rose 1.3% to $439.81.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.3% to $504.89.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) soared 1.7% to $234.91.</li>
<li>The&nbsp;Financial Sector Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) outperformed, rising 1.6%. The&nbsp;Communication Services Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) lagged, down 0.5%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul>
<li>Nvidia Corp. fell 0.6% despite surpassing Street&#8217;s consensus estimates on both earnings per share and revenue during the third quarter. Analysts have raised price targets with Wedbush at $175, Baird at $195 and Barclays at $160.</li>
<li>Despite the dismal reaction by Nvidia, semiconductor stocks, as tracked by the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) rose 1.9%. Major gainers on Thursday were Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), up 4.7%; Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), up 3.9% and Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), up 3.7%.</li>
<li>PDD Holdings Inc. &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) tumbled nearly 10% after missing earnings and revenue estimates.</li>
<li>Other stocks reacting to earnings included Deere &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), up 8.8%; Warner Music Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>), down 8%; Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>), up 1.4% and Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), up 32%.</li>
<li>Companies slated to report their earnings after the close include Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), Copart Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>), Ross Stores Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROSS#NASDAQ">ROSS</a>) and NetApp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>). </li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42118286/7-us-natural-gas-stocks-to-watch-as-henry-hub-prices-surge-50-in-november">7 US Natural Gas Stocks To Watch As Henry Hub Prices Surge 50% In November</a></li>
</ul>
Photo: Shutterstock

Large Cap

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Specialty ETFs

Eurozone

Commodities

Small Cap

Tech

ETFs

$BTC

AMAT

CPRT

SPDR Dow Jones Industrial Average ETF Trust

GOOG

GOOGL

INTU

MRVL

NTAP

NVDA

PANW

Citigourp Global Markets 2% Protected Notes Linked To The Djia

ROSS

SNOW

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Small Caps Rally, Alphabet Plummets, Bitcoin Flirts With $100,000: What's Driving Markets Thursday?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Truist Securities boosted the price target for Universal Technical Institute, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) from $22 to $26. Truist Securities analyst Jasper Bibb maintained a Buy rating. Universal Technical Institute shares closed at $19.89 on Wednesday. <a href="https://www.benzinga.com/quote/UTI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel increased the price target for Digital Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) from $195 to $205. Stifel analyst Erik Rasmussen maintained a Buy rating. Digital Realty Trust shares closed at $185.91 on Wednesday. <a href="https://www.benzinga.com/quote/DLR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities raised Wix.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) price target from $190 to $220. B. Riley Securities analyst Naved Khan maintained a Buy rating. Wix.com shares settled at $210.27 on Wednesday. <a href="https://www.benzinga.com/quote/WIX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo boosted Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) price target from $140 to $165. Wells Fargo analyst Zachary Fadem maintained an Equal-Weight rating. Williams-Sonoma shares closed at $175.04 on Wednesday. <a href="https://www.benzinga.com/quote/WSM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Rosenblatt increased NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) price target from $200 to $220. Rosenblatt analyst Hans Mosesmann maintained a Buy rating. Nvidia shares closed at $145.89 on Wednesday.  <a href="https://www.benzinga.com/quote/NVDA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS boosted Spire Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) price target from $75 to $80. UBS analyst William Appicelli maintained a Buy rating. Spire shares closed at $68.39 on Wednesday. See how other analysts view this stock.</li>
<li>Guggenheim cut the price target for AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) from $190 to $189. Guggenheim analyst Ali Faghri maintained a Buy rating. AutoNation shares settled at $164.85 on Wednesday. <a href="https://www.benzinga.com/quote/AN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen boosted Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) price target from $290 to $340. TD Cowen analyst J. Derrick Wood maintained a Hold rating. Salesforce shares closed at $325.70 on Wednesday. <a href="https://www.benzinga.com/quote/CRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group increased the price target for The TJX Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) from $138 to $142. Evercore ISI Group analyst Michael Binetti maintained an Outperform rating. TJX shares closed at $119.74 on Wednesday. <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank boosted Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) price target from $180 to $190. Deutsche Bank analyst Brad Zelnick maintained a Buy rating. Snowflake shares closed at $129.12 on Wednesday. <a href="https://www.benzinga.com/quote/snow/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NVDA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="549" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-1024x549.png" alt="" class="wp-image-659589" style="width:718px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-1024x549.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226-768x412.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21135115/image-226.png 1242w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42119232/ross-stores-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Ross Stores Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Price Target

Analyst Ratings

Trading Ideas

Nvidia To Rally More Than 50%? Here Are 10 Top Analyst Forecasts For Thursday

Legal

U.S. Justice Department Seeks To Unwind Google's Anthropic Deal

Conduit Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares are trading higher Thursday after the company announced that the Japan Patent Office granted a composition of matter patent for its lead asset, AZD1656. Here&#8217;s <a href="https://www.benzinga.com/quote/CDT/news">what you need to know.</a>
What To Know: AZD1656 is a glucokinase activator designed to target a range of autoimmune disorders. The patent approval in Japan comes after a similar patent was granted in Australia, marking continued progress in securing intellectual property protections for the company&#8217;s assets.
&#8220;This approval represents another significant milestone in our efforts to maximize the value of our intellectual property portfolio,&#8221; said David Tapolczay, CEO of Conduit Pharmaceuticals.
See Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42119232/ross-stores-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Ross Stores Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>
 AZD1656 is part of Conduit&#8217;s strategy to address unmet medical needs, particularly in diseases like Lupus and ANCA Vasculitis. Conduit Pharmaceuticals is also working on other assets, including AZD5658 and AZD5904, to expand its portfolio in the autoimmune space.
&#8220;The granting of this patent in Japan, one of the world&#8217;s largest pharmaceutical markets, underscores the strength of our scientific and intellectual property strategy. We look forward to securing additional approvals in other major markets, further enhancing our global patent coverage and bolstering our out-licensing opportunities,&#8221; Tapolczay added.
CDT Price Action: Conduit Pharmaceuticals shares were up 20.4% at 11 cents at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="548" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-1024x548.png" alt="" class="wp-image-659391" style="width:434px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-1024x548.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT-768x411.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21121818/CDT.png 1129w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42118680/elon-musk-promises-40-minute-flights-from-nyc-to-shanghai-will-prices-make-it-accessible-to-all">Elon Musk Promises 40-Minute Flights from NYC To Shanghai – Will Prices Make It Accessible To All?</a></li>
</ul>
Image Via Shutterstock.

Movers

What's Going On With Conduit Pharmaceuticals Shares Today?

Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) shares are trading higher on Thursday. The company&#8217;s shares may be moving higher in response to its acquisition target Atomic Alchemy which signed a Memorandum of Understanding (MOU) with Zeno Power. Here&#8217;s what you <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42092578/oklo-stock-slides-as-short-seller-sets-sights-on-altman-backed-nuclear-startup">need to know</a>.
What To Know: The goal of the MOU is for Atomic Alchemy to provide Zeno Power with radioisotopes like strontium-90 and americium-241 to power Zeno&#8217;s Radioisotope Power Systems (RPSs).
These systems generate energy from the heat emitted by radioisotopes, powering critical applications such as space exploration and national defense.
&#8220;We are thrilled to be working with Atomic Alchemy and Oklo to advance our fuel supply chain efforts and recover radioisotopes that otherwise would be waste,&#8221; said Harsh S. Desai, Chief Commercialization Officer at Zeno Power. 
&#8220;This partnership aims to expand access to critical isotopes, accelerating our work to meet the growing demand for reliable, persistent energy solutions from the ocean floor to the lunar surface.&#8221;
Previously, Oklo has proposed to acquire Atomic through an all-stock transaction. 
Related Link: <a href="https://www.benzinga.com/news/large-cap/24/11/42094649/nvidia-stock-historically-drops-in-december-after-q3-earnings">Nvidia Stock Historically Drops In December After Q3 Earnings</a>
OKLO Price Action: At the time of writing, Oklo shares are trading 15.8% higher at $24.27, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Courtesy of Oklo, Inc.

OKLO

What's Going On With Oklo Shares Thursday?

WIIM

BIDU

Baidu shares are trading lower. The company reported Q3 financial results.

Hewlett Packard shares are trading higher after RWE announced it will bolster its renewable energy with HPE's AI weather modeling.

Virgin Galactic Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) short percent of float has fallen 3.11% since its last report. The company recently reported that it has 6.90 million shares sold short, which is 23.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.42 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Virgin Galactic Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732214720_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Virgin Galactic Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Virgin Galactic Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Virgin Galactic Hldgs's peer group average for short interest as a percentage of float is 6.16%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

SPCE

(SPCE) - Analyzing Virgin Galactic Hldgs's Short Interest

CVS Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) short percent of float has risen 5.45% since its last report. The company recently reported that it has 21.85 million shares sold short, which is 1.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.75 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CVS Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732214715_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CVS Health has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing CVS Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CVS Health's peer group average for short interest as a percentage of float is 8.23%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(CVS) - Analyzing CVS Health's Short Interest

H&amp;R Block's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRB#NYSE">HRB</a>) short percent of float has fallen 8.29% since its last report. The company recently reported that it has 10.19 million shares sold short, which is 12.39% of all regular shares that are available for trading. Based on its trading volume, it would take traders 10.19 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>H&amp;R Block Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732214710_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for H&amp;R Block has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing H&amp;R Block's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, H&amp;R Block's peer group average for short interest as a percentage of float is 4.55%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(HRB) - Analyzing H&R Block's Short Interest

<a href="https://www.bloomberg.com/news/articles/2024-11-21/ken-griffin-says-he-s-open-to-selling-minority-stake-in-citadel">https://www.bloomberg.com/news/articles/2024-11-21/ken-griffin-says-he-s-open-to-selling-minority-stake-in-citadel</a>
&nbsp;
Ken Griffin said he would consider selling a piece of <a href="https://www.bloomberg.com/quote/9869818Z:US">Citadel</a>, the $65 billion multistrategy hedge fund he founded in 1990.
"We would be open to the possibility of selling a minority stake in Citadel at some point in the future," he said in an interview with Bloomberg on Thursday at the Economic Club of New York.

'Ken Griffin Says He's Open to Selling Minority Stake in Citadel' - Bloomberg News

CTVA

Corteva shares are trading higher after Keybanc maintained an Overweight rating on the stock and raised its price target from $66 to $69.

TopBuild shares are trading higher. The company announced it will acquire Metro Supply Company.

Cameco shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised its price target from C$75 to C$90.

CYBR

CyberArk Software shares are trading higher after the company announced it secured a QC1 certification in Italy to boost its cloud security for the public sector.

Zscaler shares are trading higher after Barclays maintained an Overweight rating on the stock and raised its price target from $200 to $220.

Wix.com shares are trading higher after multiple firms maintained Buy ratings on the stock and raised their respective price targets.

Goldman Sachs analyst Michael Ng maintained a Buy rating on Comcast Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a price target of $50.
On November 20, 2024, Comcast announced <a target="_blank" href="https://www.benzinga.com/news/global/24/11/42081224/comcast-plans-major-cable-networks-spinoff-msnbc-and-cnbc-to-form-new-public-company-report" rel="noreferrer noopener">plans to spin off</a> select cable networks and digital assets into a new publicly traded entity called SpinCo.
The proposed spin-off aims to streamline Comcast&#8217;s operations and enhance growth by separating its cable networks and complementary digital assets from its broader media and streaming divisions.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42116366/taiwan-semiconductor-plans-new-factories-annually-boosting-domestic-chip-production" rel="noreferrer noopener">Taiwan Semiconductor Plans New Factories To Boost Domestic Chip Production</a>
SpinCo assets generated approximately $7 billion in trailing twelve-month (TTM) revenue ending September 30, 2024, with an estimated EBITDA between $2 billion and $3 billion, the analyst said.
About 75% of SpinCo&#8217;s portfolio will focus on news and sports, while the remaining 25% covers general entertainment.
Comcast expects SpinCo to maintain a traditional cable network EBITDA margin of around 30%, driven by reduced Peacock-related losses and sports licensing costs.
Post-spin, Comcast&#8217;s remaining media assets (RemainCo) will include NBC broadcast, Peacock, regional sports networks, and Sky, generating an estimated $40 billion in annual revenue.
Peacock will likely remain largely unaffected by the spin, as only 2% of its content originates from SpinCo, while 98% will continue to come from RemainCo.
The spin-off positions SpinCo to pursue growth through organic initiatives and mergers or acquisitions, with a dedicated management team and tailored operational focus.
Mark Lazarus, the current chairman of NBCUniversal Media Group, will serve as SpinCo&#8217;s CEO, and Anand Kini, NBCUniversal&#8217;s CFO, will become SpinCo&#8217;s CFO and COO. Comcast expects the transaction to close within a year, pending regulatory approvals.
Ng highlighted the spin-off as a strategic move to refine Comcast&#8217;s focus on core growth drivers, including residential broadband, wireless services, and streaming.
SpinCo&#8217;s creation will likely improve CNBC and MSNBC monetization through digital subscription models and potential affiliate fee adjustments.
Ng views the separation as accretive to revenue growth while maintaining Comcast&#8217;s leverage neutrality.
Risks to the strategy include intensified cord-cutting, rising programming costs, and competitive pressures from streaming platforms.
Despite these challenges, Ng expects the spin-off to unlock shareholder value and position both SpinCo and RemainCo for sustainable growth.
Ng projected fiscal 2024 revenue of $123.42 billion and EPS of $4.24. The analyst estimates fiscal 2025 revenue of $123.43 billion and EPS of $4.43.
Price Action: CMCSA stock is up 1.59% at $43.68 at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42071334/apples-100-million-gamble-tech-giant-moves-to-lift-indonesias-iphone-ban" target="_blank" rel="noreferrer noopener">Apple&#8217;s $100 Million Gamble, Tech Giant Moves to Lift Indonesia&#8217;s iPhone Ban</a></li>
</ul>
Photo by rarrarorro on Shutterstock

Reiteration

CMCSA

Comcast's Spin-Off to Boost Broadband and Streaming Growth: Goldman Sachs

Elon Musk and Jeff Bezos,&nbsp;two of the&nbsp;<a href="https://www.benzinga.com/markets/equities/24/11/41813356/elon-musks-net-worth-soars-by-26-5-billion-in-single-day-after-tesla-stock-surges-post-trump-vic" target="_blank" rel="noopener">world&#8217;s richest people,</a>&nbsp;entered a <a href="https://www.benzinga.com/markets/equities/24/11/42105450/elon-musk-says-amazon-founder-jeff-bezos-urged-tesla-spacex-investors-to-dump-stakes-predicting-trumps-loss">social media sparring</a> match on Thursday.
What Happened: The controversy began when Musk accused Bezos of urging &#8220;everyone&#8221; to sell shares of Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) ahead of the 2024 presidential election. Musk supported Donald Trump during the presidential stakes, contributing hundreds of millions of dollars to Trump&#8217;s election efforts.
&#8220;Just learned tonight at Mar-a-Lago that Jeff Bezos was telling everyone that @realDonaldTrump would lose for sure, so they should sell all their Tesla and SpaceX stock &#x1f92d;,&#8221; Musk <a href="https://x.com/elonmusk/status/1859483544612913376">posted</a> on his social media platform, X. The post garnered over 29 million views.
Bezos responded nearly nine hours later.
&#8220;Nope. 100% not true,&#8221; the Amazon founder succinctly <a href="https://x.com/JeffBezos/status/1859615862984167549">replied</a>. 
It is unclear whether the billionaire entrepreneur plans to pursue legal action against Musk.
Tesla&#8217;s stock has far outperformed the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) since <a href="https://www.benzinga.com/markets/asia/24/11/41768811/donald-trump-wins-47th-presidency-us-futures-up-europe-up-asia-mixed-crude-falls-and-dollar-strength">Trump&#8217;s election win</a> on Nov. 5. Tesla shares are trading up 35%, breaking the $1 trillion mark, while the benchmark has gained 2.97%.
Musk is the largest shareholder of Tesla. While Musk did not start the company, he has served as CEO since 2008.
Musk and Bezos&#8217; rivalry stretches decades. Musk is the principal shareholder of SpaceX while Bezos owns Blue Origin, two space exploration companies.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/42119020/alphabet-bleeds-over-120-billion-in-market-value-eyes-worst-day-in-10-months-after-doj-demands-google-chrome-sale">Alphabet Bleeds Over $120 Billion In Market Value, Eyes Worst Day In 10 Months After DOJ Demands Google Chrome Sale</a></li>
</ul>
Photos: lev radin and Kathy Hutchins on Shutterstock

Entertainment

Equities

Social Media

Politics

TSLA

Jeff Bezos Denies Elon Musk's Allegation That He Told People To Sell Tesla Stock: '100% Not True'

Medicine Man Technologies (SHWZ) has issued an announcement. Nuevo Holding, LLC, a subsidiary of Medicine Man Technologies, Inc., amended its promi...

Medicine Man Technologies Refinances, Extends Loan Maturities

Medicine Man Technologies Q2 2024 Earnings Preview

Here's the major earnings after the close today

Medicine Man Technologies, Inc. (SHWZ) Q2 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Medicine Man Technologies (OTCMKTS:<a href="https://investorplace.com/stock-quotes/shwz-stock-quote/">SHWZ</a>) just reported results for the second quarter of 2024.<ul><li>Medicine Man Technologies reported earnings per share of -20 cents. This was below the analyst estimate for EPS of -19 cents.</li><li>The company reported revenue of $43.24 million.</li><li>This was 2.94% better than the analyst estimate for revenue of $42.00 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/shwz-stock-earnings-medicine-man-technologies-for-q2-of-2024/">SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q2 2024

In a report released today, Mike Hickey from Benchmark Co. assigned a Buy rating to Medicine Man Technologies (SHWZ – Research Report), with a pric...

Medicine Man Technologies (SHWZ) Receives a Buy from Benchmark Co.

In a report released today, Joe Gomes from Noble Financial maintained a Buy rating on Medicine Man Technologies (SHWZ – Research Report), with a pr...

Noble Financial Keeps Their Buy Rating on Medicine Man Technologies (SHWZ)

Medicine Man Technologies (SHWZ) has released an update. Medicine Man Technologies, Inc. has released its second quarter financial results for the ...

Medicine Man Technologies Announces Q2 Results

Medicine Man Technologies GAAP EPS of -$0.20

Schwazze announces preliminary Q3 results

ACHV

ARMN

ASXC

BEEM

CTSO

CURI

DPRO

DRRX

FLUT

GROY

HIVE

IMOS

KNTNF

LAAC

LGMK

MRCY

NVVE

NWHUF

OUST

QFIN

QUIK

REED

RKDA

VTGN

WPRT

ZVRA

Press Releases

Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET

Schwazze Announces First Quarter 2024 Financial Results

General

Schwazze Announces Grand Opening of its 35th New Mexico Dispensary in Bernalillo

Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing

Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET

Schwazze Announces Second Quarter 2024 Financial Results

Schwazze Announces Preliminary Third Quarter 2024 Financial Results

Benchmark

Comments

Medicine Man Technologies

Medicine Man Technologies (SHWZ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga